Stock listing
Lang & Schwarz:A3EQWL MIRA Pharmaceuticals, Inc. Aktie
German listing (Lang & Schwarz) of MIRA Pharmaceuticals, Inc. · home listing NASDAQ:MIRA
Follow MIRA Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:MIRA
$0.629 USD -0.053 (-7.8%)
Close on Oct 22, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:MIRA
- Day range
- $0.622 – $0.730 USDOct 22, 2026
- Volume
- 100,247 sharesOct 22, 2026
- Market cap
- $26.44M USDAt the close on Oct 22, 2026 · price × 42.04M shares outstanding

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MIRA · Home | $0.629 USD | -0.053 (-7.8%) | 100,247 | $0.730 | $0.730 | $0.622 | $0.682 | Close on Oct 22, 2026 |
| Frankfurt:K6S | €0.604 EUR | +0.047 (+8.5%) | — | €0.586 | €0.604 | €0.586 | €0.556 | Close on Oct 22, 2026 |
Daily closes
Last 3 months, Jul 22, 2026 – Oct 22, 2026 · NASDAQ:MIRA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.629 | -0.053 | -7.8% | $0.730 | $0.730 | $0.622 | 100,247 | |
| $0.682 | +0.032 | +4.9% | $0.665 | $0.693 | $0.665 | 127,965 | |
| $0.650 | +0.008 | +1.2% | $0.645 | $0.661 | $0.645 | 10,462 | |
| $0.642 | +0.010 | +1.5% | $0.626 | $0.647 | $0.624 | 66,029 | |
| $0.632 | -0.026 | -3.9% | $0.680 | $0.680 | $0.631 | 123,143 | |
| $0.658 | -0.024 | -3.5% | $0.635 | $0.679 | $0.626 | 128,627 | |
| $0.682 | +0.016 | +2.4% | $0.667 | $0.686 | $0.660 | 75,763 | |
| $0.666 | -0.039 | -5.5% | $0.699 | $0.699 | $0.660 | 67,694 | |
| $0.705 | -0.040 | -5.4% | $0.759 | $0.759 | $0.685 | 89,517 | |
| $0.746 | +0.043 | +6.0% | $0.720 | $0.750 | $0.703 | 52,431 | |
| $0.703 | -0.007 | -1.0% | $0.710 | $0.710 | $0.681 | 142,664 | |
| $0.710 | -0.002 | -0.3% | $0.722 | $0.741 | $0.703 | 67,731 | |
| $0.712 | -0.024 | -3.3% | $0.759 | $0.760 | $0.700 | 105,700 | |
| $0.736 | +0.006 | +0.8% | $0.730 | $0.750 | $0.711 | 86,400 | |
| $0.730 | +0.007 | +1.0% | $0.730 | $0.758 | $0.711 | 158,000 | |
| $0.723 | -0.122 | -14.4% | $0.840 | $0.850 | $0.620 | 667,700 | |
| $0.845 | -0.027 | -3.1% | $0.859 | $0.869 | $0.820 | 72,100 | |
| $0.872 | -0.031 | -3.4% | $0.870 | $0.900 | $0.865 | 61,400 | |
| $0.903 | +0.003 | +0.3% | $0.898 | $0.911 | $0.875 | 65,800 | |
| $0.900 | +0.060 | +7.1% | $0.860 | $0.900 | $0.850 | 94,700 | |
| $0.840 | -0.018 | -2.1% | $0.858 | $0.860 | $0.831 | 54,100 | |
| $0.858 | -0.048 | -5.3% | $0.936 | $0.940 | $0.850 | 118,600 | |
| $0.906 | +0.027 | +3.1% | $0.865 | $0.919 | $0.847 | 127,800 | |
| $0.879 | +0.047 | +5.6% | $0.821 | $0.900 | $0.798 | 387,600 | |
| $0.832 | +0.073 | +9.6% | $0.789 | $0.832 | $0.770 | 682,600 | |
| $0.759 | +0.039 | +5.4% | $0.730 | $0.760 | $0.722 | 131,400 | |
| $0.720 | +0.006 | +0.8% | $0.720 | $0.737 | $0.710 | 76,500 | |
| $0.714 | -0.039 | -5.2% | $0.753 | $0.754 | $0.714 | 71,500 | |
| $0.753 | -0.021 | -2.7% | $0.766 | $0.780 | $0.728 | 171,500 | |
| $0.774 | -0.015 | -1.9% | $0.789 | $0.820 | $0.774 | 105,500 | |
| $0.789 | +0.008 | +1.0% | $0.790 | $0.830 | $0.759 | 138,400 | |
| $0.781 | +0.005 | +0.6% | $0.771 | $0.794 | $0.756 | 53,200 | |
| $0.776 | +0.012 | +1.6% | $0.760 | $0.810 | $0.751 | 177,200 | |
| $0.764 | +0.024 | +3.2% | $0.735 | $0.850 | $0.735 | 338,500 | |
| $0.740 | -0.110 | -12.9% | $0.830 | $0.840 | $0.731 | 490,500 | |
| $0.850 | -0.010 | -1.2% | $0.857 | $0.935 | $0.825 | 575,000 | |
| $0.860 | +0.090 | +11.7% | $0.740 | $1.100 | $0.721 | 29,281,100 | |
| $0.770 | +0.020 | +2.7% | $0.750 | $0.782 | $0.750 | 44,300 | |
| $0.750 | -0.020 | -2.6% | $0.750 | $0.779 | $0.750 | 31,800 | |
| $0.770 | +0.020 | +2.7% | $0.750 | $0.778 | $0.740 | 44,100 | |
| $0.750 | -0.025 | -3.2% | $0.770 | $0.774 | $0.750 | 27,300 | |
| $0.775 | -0.013 | -1.6% | $0.800 | $0.810 | $0.768 | 34,700 | |
| $0.788 | +0.024 | +3.1% | $0.779 | $0.825 | $0.770 | 65,100 | |
| $0.764 | +0.054 | +7.6% | $0.720 | $0.820 | $0.720 | 117,400 | |
| $0.710 | -0.060 | -7.8% | $0.770 | $0.796 | $0.710 | 41,700 | |
| $0.770 | +0.005 | +0.7% | $0.760 | $0.800 | $0.760 | 41,100 | |
| $0.765 | -0.025 | -3.2% | $0.765 | $0.795 | $0.760 | 40,300 | |
| $0.790 | +0.010 | +1.3% | $0.800 | $0.810 | $0.774 | 60,000 | |
| $0.780 | +0.030 | +4.0% | $0.782 | $0.811 | $0.766 | 75,500 | |
| $0.750 | +0.011 | +1.5% | $0.770 | $0.825 | $0.750 | 83,800 | |
| $0.739 | -0.039 | -5.0% | $0.773 | $0.785 | $0.738 | 26,400 | |
| $0.778 | +0.010 | +1.4% | $0.803 | $0.803 | $0.771 | 18,568 | |
| $0.767 | +0.027 | +3.7% | $0.759 | $0.790 | $0.741 | 114,143 | |
| $0.740 | +0.062 | +9.1% | $0.680 | $0.750 | $0.670 | 156,300 | |
| $0.678 | +0.020 | +3.0% | $0.698 | $0.698 | $0.659 | 71,400 | |
| $0.658 | -0.017 | -2.5% | $0.676 | $0.690 | $0.638 | 69,900 | |
| $0.675 | +0.061 | +9.9% | $0.654 | $0.730 | $0.650 | 352,300 | |
| $0.614 | -0.178 | -22.5% | $0.778 | $0.850 | $0.600 | 424,200 | |
| $0.792 | -0.024 | -2.9% | $0.835 | $0.835 | $0.772 | 87,500 | |
| $0.816 | -0.026 | -3.1% | $0.851 | $0.897 | $0.800 | 68,600 | |
| $0.842 | +0.002 | +0.2% | $0.860 | $0.865 | $0.831 | 49,500 | |
| $0.840 | -0.042 | -4.8% | $0.880 | $0.920 | $0.831 | 37,700 | |
| $0.882 | 0.000 | 0.0% | $0.880 | $0.950 | $0.870 | 26,300 | |
| $0.882 | -0.046 | -5.0% | $0.950 | $0.950 | $0.830 | 89,300 | |
| $0.928 | 0.000 | 0.0% | $0.900 | $0.950 | $0.885 | 88,100 | |
| $0.928 | +0.011 | +1.2% | $0.909 | $0.928 | $0.909 | 25,300 |
- Ticker
- Lang & Schwarz:A3EQWL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Sep 17, 2026
MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 30 slides
Latest news
MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
Sep 17, 2026
Closed $0.759 (+5.4%) on Sep 17, 2026
MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND
Sep 1, 2026
Closed $0.86 (+11.7%) on Sep 1, 2026
MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
Aug 6, 2026
Closed $0.678 (+3.0%) on Aug 6, 2026
MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies
Jul 30, 2026
Closed $0.816 (-3.1%) on Jul 30, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 30 slides · October 2026
Investor Presentation (April 2026)
Investor deck · 56 slides · April 2026
MIRA Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 76 in all · newest Sep 17, 2026 · oldest 2023
- Decks
- 2 decks · latest October 2026
Where MIRA Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MIRA · Home listing | NASDAQ | United States | USD |
| gettex:K6S | gettex | Germany | EUR |
| Lang & Schwarz:A3EQWL · This page | Lang & Schwarz | Germany | EUR |
| LS Exchange:A3EQWL | LS Exchange | Germany | EUR |
| BOATS:MIRA | BOATS | United States | USD |
| Tradegate:K6S | Tradegate | Germany | EUR |
| Dusseldorf:K6S | Dusseldorf | Germany | EUR |
| Frankfurt:K6S | Frankfurt | Germany | EUR |
| Hamburg:K6S | Hamburg | Germany | EUR |
| Munich:K6S | Munich | Germany | EUR |
| Stuttgart:K6S | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about MIRA Pharmaceuticals, Inc.